ArticleNPJ breast cancer2018
21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer.
Charles E Geyer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
61 papers cite itlatest 60 shown
this paperpooled ittrialcites it